Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »
Reset 

Medical Research Stock Performance Review -- Agilent Technologies, Alere, Quintiles IMS, and Thermo Fisher Scientific

NEW YORK, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017

Capricor Therapeutics to Present Six-Month Results from the Randomized HOPE Trial of CAP-1002 in Duchenne Muscular Dystrophy in a Late Breaking Session of the World Muscle Society

LOS ANGELES, Sept. 18, 2017 /PRNewswire/ -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological therapies for Duchenne muscular dystrophy (DMD) and other rare diseases, today announced... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Capricor Therapeutics, Inc.

Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer

SAN DIEGO, Sept. 18, 2017 /PRNewswire/ -- Abide Therapeutics, a developer of innovative pharmaceuticals, announced today the appointment of Sapna Srivastava, Ph.D., to the position of Chief Financial and Strategy Officer. Dr.... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Abide Therapeutics Inc.

MeMed Completes Trilogy of Clinical Studies with More Than 2,000 Patients Validating First Ever Blood Test to Accurately Distinguish Between Bacterial and Viral Infections

TIRAT CARMEL, Israel, September 18, 2017 PRNewswire/ -- MeMed today announced positive results from a large, external double-blinded PATHFINDER study that met its primary endpoint, independently confirming that MeMed's novel blood test, ImmunoXpert(TM), accurately distinguishes between bacterial... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017

Oncolytics Biotech® Announces Successful End-of-Phase 2 Meeting with FDA for REOLYSIN® in Metastatic Breast Cancer

Outcome supports focus on HR+/HER2- patient group that reported an
effective doubling of median overall survival from 10.8 to 21.0 months

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Western Oncolytics

Lexicon Pharmaceuticals To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference

THE WOODLANDS, Texas, Sept. 18, 2017 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it will present at the following conference:

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Lexicon Pharmaceuticals, Inc.

OTC Markets Group Welcomes Covalon Technologies to OTCQX

NEW YORK, Sept. 18, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Stanton Continues To Expand in Texas with New Store in Amarillo

AMARILLO, Texas, Sept. 18, 2017 /PRNewswire-iReach/ -- Stanton Optical, one of the fastest growing retail optical centers, will be opening their first store in Amarillo, which will be the company's eleventh location in the state of Texas. This new Stanton Optical store will be located at 3505... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017

RXi Pharmaceuticals to Present at BioPharm America's 10th Annual International Partnering Conference

MARLBOROUGH, Mass., Sept. 18, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, announced today that Dr. James Cardia, Director of Business Development and Intellectual... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  RXi Pharmaceuticals Corporation

Stock Performance Review on Biotech Industry -- Galena Biopharma, Idera Pharma, Ignyta, and Jaguar Health

NEW YORK, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Galena Biopharma, Inc. | Ignyta, Inc. | Jaguar Health, Inc. | Idera Pharmaceuticals Inc.

Addex Makes Changes to Executive Management Team

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017
Related companies:  Addex Therapeutics S.A.

INNATE PHARMA, First half of 2017: delivering key clinical data and strengthening the pipeline

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017
Related companies:  Innate Pharma S.A. | Innate Immunotherapeutics Limited | Innate Immunotherapeutics Limited

ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017
Related companies:  ThromboGenics NV

Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017
Related companies:  Immunocore Limited

Saniona AB: Saniona reports encouraging start for tesofensine Phase 3 study

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017
Related companies:  Saniona

Cambridge Medical Robotics closes Series A fundraise with further $26 million

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017
Related companies:  Hisamitsu Pharmaceutical Co., Inc.

The 8th China (Taizhou) International Medical Expo Was Held in Taizhou Jiangsu Province

TAIZHOU, China, Sept. 18, 2017 /PRNewswire/ -- From Sept. 15 to 17, the 8th China (Taizhou) International Medical Expo was held in China Medical City of Taizhou. This Expo has attracted 948 enterprises from 20 countries and regions including China, US, Germany, France, UK, and Japan, etc., and... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017

Tetracore® Inc. Announces European Approval of the T-COR 8(TM) Portable Real-time PCR Thermocycler

The next generation molecular diagnostics platform introduces novel connectivity solution designed to bring testing closer to the patient

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Tetracore, Inc.

BioVentrix announces the 1st Revivent TC(TM) TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment at the University Heart Center Zurich in Switzerland

SAN RAMON, Calif., and ZURICH, Sept. 18, 2017 /PRNewswire/ -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced the first clinical use of its closed-chest... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  BioVentrix, Inc.

Braeburn Announces FDA Acceptance with Priority Review of New Drug Application for CAM2038 Buprenorphine Depot for the Treatment of Opioid Use Disorder

PRINCETON, N.J., Sept. 18, 2017 /PRNewswire/ -- Braeburn Pharmaceuticals, Inc. (Braeburn) announces that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) with Priority Review designation for CAM2038, an investigational buprenorphine weekly and monthly depot... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »
to the top ↑